Efficient reverse genetics approach involving infectious subgenomic amplicon for engineering dengue virus.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
08 2023
Historique:
revised: 09 07 2023
received: 25 04 2023
accepted: 11 07 2023
medline: 31 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: ppublish

Résumé

Dengue virus, which belongs to the Flaviviridae family, can induce a range of symptoms from mild to severe, including dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. While infectious cloning technology is a useful tool for understanding viral pathogenesis and symptoms, it exhibits limitations when constructing the entire Flavivirus genome. The instability and toxicity of the genome to bacteria make its full-length construction in bacterial vectors a time-consuming and laborious process. To address these challenges, we employed the modified infectious subgenomic amplicon (ISA) method in this study, which can potentially be a superior tool for reverse genetic studies on the dengue virus. Using ISA, we generated recombinant dengue viruses de novo and validated their robust replication in both human and insect cell lines, which was comparable to that of the original strains. Moreover, the efficiency of ISA in genetically modifying the dengue virus was elucidated by successfully inserting the gene for green fluorescence protein into the genome of dengue virus serotype 4. Overall, this study highlighted the effectiveness of ISA for genetically engineering the dengue virus and provided a technical basis for a convenient reverse genetics system that could expedite investigations into the dengue virus.

Identifiants

pubmed: 37515534
doi: 10.1002/jmv.28978
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e28978

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Wagenaar JFP, Mairuhu ATA, van Gorp ECM. Genetic influences on dengue virus infections. World Health Organization Regional Office for South-East Asia. 2004;28:126-134.
World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention, and Control. WHO; 2009.
Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol Med Microbiol. 2000;28:183-188.
Dejnirattisai W, Jumnainsong A, Onsirisakul N, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745-748.
Katzelnick LC, Gresh L, Halloran ME, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358:929-932.
Nimmanitya S, Kliks SC, Burke DS, Nisalak A. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg. 1988;38:411-419.
Brandt WE, Kliks SC, Wahl L, Nisalak A, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg. 1989;40:444-451.
Pang T, Cardosa MJ, Guzman MG. Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol. 2007;85:43-45.
Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496:504-507.
Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16:935-941.
Ooi EE, Gubler DJ. Dengue in Southeast Asia: epidemiological characteristics and strategic challenges in disease prevention. Cadernos de Saúde Pública. 2009;25(suppl 1):S115-S124.
Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11:480-496.
Kuno G. Research on dengue and dengue-like illness in East Asia and the Western Pacific during the first half of the 20th century. Rev Med Virol. 2007;17:327-341.
Cho K, Park SY, Lee WC, Lee MJ, Lee J. International travel and exotic dengue fever in South Korea from 2006 to 2015. Jpn J Infect Dis. 2018;71:378-381.
Miki S, Lee WC, Lee MJ. A comparative study of the trends of imported dengue cases in Korea and Japan 2011-2015. J Clin Med Res. 2017;9:650-653.
Neumann G, Kawaoka Y. Reverse genetics systems for the generation of segmented negative-sense RNA viruses entirely from cloned cDNA. Curr Top Microbiol Immunol. 2004;283:43-60.
Aubry F, Nougairède A, Gould EA, de Lamballerie X. Flavivirus reverse genetic systems, construction techniques, and applications: a historical perspective. Antiviral Res. 2015;114:67-85.
Aubry F, Nougairède A, de Fabritus L, Querat G, Gould EA, de Lamballerie X. Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons. J Gen Virol. 2014;95:2462-2467.
Mélade J, Piorkowski G, Touret F, et al. A simple reverse genetics method to generate recombinant coronaviruses. EMBO Rep. 2022;23:e53820.
Edmonds J, van Grinsven E, Prow N, et al. A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity. J Virol. 2013;87:2367-2372.
Hwang EH, Kim G, Chung H, et al. Molecular evolution of dengue virus types 1 and 4 in Korean travelers. Arch Virol. 2021;166:1103-1112.
Go YY, Jung E, Balasuriya UBR. Complete genome sequences of three laboratory strains of dengue virus (Serotypes 2, 3, and 4) available in South Korea. Genome Announc. 2015;3:e01389-15.
Park C, Baek JH, Cho SH, et al. Field porcine reproductive and respiratory syndrome viruses (PRRSV) attenuated by codon pair deoptimization (CPD) in NSP1 protected pigs from heterologous challenge. Virology. 2020;540:172-183.
Christenbury JG, Aw PPK, Ong SH, et al. A method for full genome sequencing of all four serotypes of the dengue virus. J Virol Methods. 2010;169:202-206.
Suphatrakul A, Duangchinda T, Jupatanakul N, et al. Multi-color fluorescent reporter dengue viruses with improved stability for analysis of a multi-virus infection. PLoS One. 2018;13:e0194399.
Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nature Med. 2004;10:S98-S109.
Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. PLoS Neglected Trop Dis. 2013;7:e2055.
Pu SY, Wu RH, Tsai MH, Yang CC, Chang CM, Yueh A. A novel approach to propagate flavivirus infectious cDNA clones in bacteria by introducing tandem repeat sequences upstream of virus genome. J Gen Virol. 2014;95:1493-1503.
Atieh T, Nougairède A, Klitting R, et al. New reverse genetics and transfection methods to rescue arboviruses in mosquito cells. Sci Rep. 2017;7:13983.
Ren L, Peng Z, Chen X, Ouyang H. Live cell reporter systems for positive-sense single strand RNA viruses. Appl Biochem Biotechnol. 2016;178:1567-1585.

Auteurs

Chang-Joo Park (CJ)

Department of Microbiology and Immunology, Eulji University School of Medicine, Daejeon, Republic of Korea.

Yoon-A Lee (YA)

Department of Microbiology and Immunology, Eulji University School of Medicine, Daejeon, Republic of Korea.

Seung-Min Yoo (SM)

Department of Microbiology and Immunology, Eulji University School of Medicine, Daejeon, Republic of Korea.

Geon A Kim (GA)

Department of Biomedical Laboratory Science, School of Healthcare Science, Eulji University, Uijeongbu, Republic of Korea.

Myung-Shin Lee (MS)

Department of Microbiology and Immunology, Eulji University School of Medicine, Daejeon, Republic of Korea.

Changhoon Park (C)

Department of Microbiology and Immunology, Eulji University School of Medicine, Daejeon, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH